OFFICIAL PUBLICATION OF

by its subsidiary APPco

World news wrapup: 21 September 2023

Nicholas O’Donoghue 21/09/2023

Eli Lilly takes action over copy-cat Mounjaro; Pope praises papal pharmacy staff; Pharmacist facing fraudulent export charges US: Pharmaceutical giant, Eli Lilly, is taking legal action against a number of pharmacies, spas and wellness centres, for selling products claiming to contain tirzepatide, the active ingredient in its diabetes medication, Mounjaro. The company alleged that

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

World news wrapup: 21 September 2023

Previous Pharmacists ‘struggling’ to find prescribing preceptors

Next No surge in demand for 60-day medications: wholesaler

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Pharmacists ‘struggling’ to find prescribing preceptors

Next No surge in demand for 60-day medications: wholesaler

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.